Investment Rating - The report maintains a "Buy" rating for the company [1][8]. Core Insights - The company achieved record high revenue and profit, driven by significant growth in its sub-healthcare segment [5]. - The company's revenue for H1 2025 reached 1.459 billion RMB, a year-on-year increase of 28.2%, with a net profit of 171 million RMB, up 35.5% year-on-year [5]. - The "internal + external" strategy is expected to continue driving growth, with projected revenues of 3 billion RMB in 2025, 3.4 billion RMB in 2026, and 3.7 billion RMB in 2027 [5]. Financial Performance - The company reported a gross margin of 49.3% for H1 2025, an increase of 2.3 percentage points year-on-year [5]. - The operating cash flow for H1 2025 was 410 million RMB, reflecting an 84.4% increase year-on-year [5]. - As of June 30, 2025, the company had cash and cash equivalents totaling 2 billion RMB, a 27.5% increase year-on-year [5]. Business Segments - The beauty and wellness services segment generated revenue of 807 million RMB in H1 2025, a year-on-year increase of 29.6% [5]. - The medical beauty segment reported revenue of 499 million RMB, up 13.0% year-on-year, driven by increased patient visits [5]. - The sub-healthcare services segment saw remarkable growth, with revenue reaching 154 million RMB, a 107.8% increase year-on-year [5]. Membership Growth - The company experienced a 46.5% year-on-year increase in active members, reaching 120,000 members [5]. - The number of visitors to direct-operated stores exceeded 920,000 in H1 2025, representing a 47.8% increase year-on-year [5]. Future Projections - The company forecasts revenue growth of 18% in 2025, followed by 10% in 2026 and 9% in 2027 [5]. - The projected net profit for 2025 is 300 million RMB, with expected growth rates of 34% in 2025, 15% in 2026, and 15% in 2027 [5].

Overall Performance - In the first half of 2025, companies listed on the Beijing Stock Exchange achieved a total operating income of 92.064 billion yuan, with an average operating income of 336 million yuan, reflecting a year-on-year growth of 6.01% [2] - The total net profit attributable to shareholders was 5.909 billion yuan, with an average net profit of 21.5646 million yuan, showing a decline of 10.59%, although the decline rate has narrowed [2] - Over 60% of companies reported revenue growth, with 225 companies profitable, resulting in a profitability rate of 82.12% [2] - In Q2, companies reported a total operating income of 50.547 billion yuan, a quarter-on-quarter increase of 21.75%, and a net profit of 3.133 billion yuan, up 12.88% from the previous quarter [2] Industry Highlights - The automotive industry showed strong performance, with net profit growth of 23.63% in the first half of the year, driven by policies promoting vehicle upgrades [3] - Companies in the beauty and textile sectors also benefited from consumer trends, with net profit growth of 26.12% and 42.91%, respectively [3] - The equipment manufacturing sector maintained rapid growth, with net profit increasing by 15.95% [3] R&D Investment - Companies on the Beijing Stock Exchange increased R&D spending to 4.139 billion yuan, a year-on-year increase of 2.59%, with significant investments in information technology and biomedicine [4] - Eight companies had R&D expenditures exceeding 30% of their operating income, while four companies invested over 100 million yuan in R&D [4] - A total of 72 companies implemented equity incentive plans, covering 4,266 individuals, to attract and retain talent [4] Financing and M&A Activities - In 2025, 12 companies raised a total of 3.856 billion yuan through public offerings, while five companies announced targeted convertible bond issuances totaling 704 million yuan [5] - Eleven companies disclosed cash asset purchase announcements, with a total transaction amount of 2.650 billion yuan [6] - Significant mergers and acquisitions were noted, such as Xujie Technology's acquisition of a stake in a downstream photovoltaic power station investment and operation company [6] Investor Relations and Market Performance - Approximately 70% of listed companies implemented cash dividends, totaling 4.974 billion yuan, an increase of 5.35% year-on-year [7] - The number of qualified investors reached 8.6613 million, an increase of 675,600 from the previous year, with daily average trading participation of 343,700 investors [8] - The average daily trading volume was 29.625 billion yuan, with the market showing a positive trend following the launch of the Beijing Stock Exchange Specialized Index [8]

涨跌 (%) 收盘 指数 1月 名称 (点) 1日 5日 -0.45 8.38 -0.26 上证指数 3828 | 风格指数 (%) | FEE | 近１个月 近６个月 | | | --- | --- | --- | --- | | 大盘指数 | -0.57 | 11.37 | 16 | | 中盘指数 | -2.13 | 13.14 | 17.92 | | 小盘指数 | -2.48 | 9.84 | 16.95 | | 涨幅居前 行业(%) | 바람들 | 近１个月 近６个月 | | | 衣商行II | 2.54 | 0.41 | 14.95 | | 国有大型银行II | 2.11 | 2.82 | 13.82 | | 股份制银行II | 1.95 | -2.3 | 7.84 | | 白色家电 | 1.78 | 2.14 | 2.45 | | 饰品 | 1.66 | 6.96 | 34.32 | | 跌幅居前 行业(%) | MEE | 近１个月 近６个月 | | | 通信设备 | -6.71 | 46.84 | 94.07 | | 其他电源设备Ⅱ | -5.71 | 14.99 | 22.82 | | 元件 ...

Group 1: Overall Performance - In the first half of 2025, companies listed on the Beijing Stock Exchange demonstrated resilience and growth potential, with total operating revenue reaching 92.064 billion yuan, an increase of 6.01% year-on-year [1] - The net profit attributable to shareholders was 5.909 billion yuan, with an average net profit of 21.5646 million yuan per company, reflecting a year-on-year decline of 10.59%, but the decline has narrowed compared to previous years [1] - Over 60% of companies reported revenue growth, with 225 companies profitable, resulting in a profitability rate of 82.12% [1] Group 2: Sector Highlights - The consumer sector showed policy-driven growth, particularly in the automotive industry, where companies like Kaitie achieved approximately 40% growth in both revenue and net profit [2] - The beauty and textile industries also thrived, with companies like Taihu Snow reporting a net profit increase of 69.77% [2] - Equipment manufacturing maintained rapid growth, exemplified by Wantong Hydraulic's net profit growth of 40.33% [2] Group 3: Innovation and Investment - Companies increased R&D investment, totaling 4.139 billion yuan, a year-on-year increase of 2.59%, with leading sectors being information technology and biomedicine [3] - Twelve companies completed public financing totaling 3.856 billion yuan, and five companies planned to issue a total of 704 million yuan in targeted convertible bonds [3] - Eleven companies disclosed cash acquisitions totaling 2.650 billion yuan, indicating active mergers and acquisitions for industry integration and transformation [3]

证 券 研 究 报 告 科技制造引领，寻找景气成长 ——北交所25年二季报总结 2025.09.02 证券分析师：刘靖 A0230512070005 研究支持： 吕靖华 A0230124070002 主要内容 2 ◼ 北证二季报盈利压力再现。截至25Q2，北证单季营收增速+4.9%、环比-0.4pct，单季归母净利润增速-16.6%、环比 -8.8pct，ROEttm达+6.0%、环比-0.1pct；拆分ROE来看，25Q2，北证资产周转率TTM达62.6%、环比+0.5pct， 北证销售净利率TTM达5.5%、环比-0.2pct。其中，盈利压力主要源于两方面，1）Q2海外扰动影响显现，我国对美 出口增速大幅下滑，25Q2，北证出口50%以上企业单季扣非净利润增速转负、达-4.4%，环比-21.0pct。2）供给压 力、北证固定资产增速达历史高位，25Q2，北证固定资产增速达+30.2%、环比+2.0pct，处于历史高位，对北证盈 利能力形成压力，25Q2北证毛利率TTM达22.4%、环比-0.3pct，下滑幅度高于其他板块。展望后续，固定资产增速 的拐点有望在下半年出现，关注北证供给优化后的盈利弹性，截至2 ...

Core Viewpoint - The overall profitability growth of A-share listed companies is slowing down due to continuous price declines and weak effective demand, despite some improvements in revenue [1][2] Profitability Analysis - The net profit growth of listed companies has narrowed, with quarterly net profit growth rates for 2024Q4, 2025Q1, and 2025Q2 being -15.7%, 3.2%, and 1.2% respectively [2] - Non-financial oil and petrochemical sectors show even more significant declines, with quarterly net profit growth rates of -50.2%, 4.5%, and -0.1% for the same periods [2] Revenue Trends - A-share companies have seen an improvement in quarterly revenue growth compared to 2025Q1, with growth rates of 1.4%, -0.3%, and 0.4% for 2024Q4, 2025Q1, and 2025Q2 respectively [2] - Non-financial oil and petrochemical sectors also show improved revenue growth rates of 1.2%, 0.5%, and 0.9% for the same quarters [2] Sector Performance - Key sectors showing improved profitability include healthcare, midstream manufacturing, and financial real estate, with information technology leading in profit growth [4] - The quarterly profit growth rates for 2025Q2 are ranked as follows: Information Technology > Midstream Manufacturing > Financial Real Estate > Healthcare > Utilities > Consumer Services > Resource Products [4] Cash Flow and Capital Expansion - Free cash flow as a percentage of market value and revenue is steadily increasing, with operating cash flow showing high growth, particularly from midstream manufacturing [5] - Capital expenditure growth has declined since reaching a peak in Q2 2023, with limited recovery in demand and low corporate capital expansion willingness [5] Focus Areas for Growth - Industries with high or improving profit growth in 2025Q2 include TMT (software development, gaming, components, communication devices, other electronics, semiconductors, consumer electronics), mid-to-high-end manufacturing, and certain resource products [6]

招商证券认为，9月市场风格可能相对偏大盘，成长风格有望继续占优，建议重点关注受益于PPI触底、 美联储降息的领域，以及业绩增速较高且有望迎来拐点的领域，包括电子（半导体、消费电子）、计算 机（计算机设备、软件开发）、电力设备（电池、光伏设备、风电设备）、机械设备（自动化设备、工 程机械）、美容护理等细分行业。 编辑：罗浩 转自：中国证券报 新华财经北京9月1日电 8月A股行情向好，各类投资机构调研上市公司热情高涨。记者梳理发现，不少 上半年业绩优异的标的，成为机构调研中的"香饽饽"。 以德赛西威为例，公司2025年上半年实现归母净利润12.23亿元，同比增长逾45%，其8月以来累计接待 351家机构调研，在同期接待调研的上市公司中高居第二位。调研纪要显示，公司智能化产品全栈的能 力布局、政策对公司智能驾驶业务未来发展影响等问题被机构关注。 德赛西威表示，公司具备领先且灵活的硬件货架快速开发能力、深度软件设计与开发能力、软件算法的 顶层布局等，通过多个维度着力打造先进的智驾系统解决方案以及无人配送物流车解决方案。 包括德赛西威在内，三花智控、天孚通信、新易盛、九号公司-WD等2025年上半年归母净利润均较上年 ...

证券研究报告·策略报告·策略深度报告 ◼ 行业分析：上游景气分化，中游利润复苏，下游消费业绩承压，TMT 整 体表现亮眼 总体来看，2025Q2 归母净利润同比增长靠前的行业是综合（+239.7%）、钢 铁（+82.2%）、电子（+27.6%）、电力设备（+24.6%）、建筑材料（+23.7%）、 传媒（+20.1%）、计算机（+20.1%）。 策略深度报告 20250831 2025 年中报深度分析：盈利表现韧性，ROE 底部企稳——A 股财报深度分析系列（八） [Table_Summary] ◼ 整体分析： 2025Q2 全 A 两非盈利回踩，ROE 低位企稳 全 A 两非盈利出现回踩，Q2 增速转负。全 A 2025H1 归母净利润累计同 比增速为 2.57%，较 2025Q1 出现小幅回踩，2025Q2 单季度归母净利润同 比增速为 1.41%；全 A 两非 2025H1 归母净利润累计同比增速为 2.61%， 同样较 2025Q1 有所回落，2025Q2 单季度归母净利润同比增速转负，为- 0.14%。 两非利润表拆解：2025H1 毛利润同比小幅提升，毛利率略低于 2024H1。 费用同比降低，其 ...

Core Insights - The food and beverage industry maintains the highest gross margin at 51.41% in the first half of the year, excluding the financial sector [1] - The beauty and personal care, as well as the media industries, rank second and third in gross margin [1] - The pharmaceutical and computer sectors dominate individual stock performance, with the top five companies by gross margin being Hai Chuang Pharmaceutical-U, Ailis, Dameng Data, Dize Pharmaceutical-U, and Zhongwang Software [1] - Hai Chuang Pharmaceutical-U leads with an impressive gross margin of 99.52%, while 27 companies reported gross margins exceeding 90% in the first half of the year [1]

Core Viewpoint - The stock of Steady Medical (300888) has shown a positive performance with a closing price of 42.36 yuan, reflecting a 1.17% increase as of August 29, 2025, despite a net outflow of main funds [1][2]. Financial Performance - Steady Medical reported a main revenue of 5.296 billion yuan for the first half of 2025, representing a year-on-year increase of 31.31% [3]. - The net profit attributable to shareholders was 492 million yuan, up 28.07% year-on-year, while the net profit after deducting non-recurring gains and losses was 461 million yuan, increasing by 40.9% [3]. - In Q2 2025, the company achieved a single-quarter main revenue of 2.691 billion yuan, a 26.66% increase year-on-year, and a net profit of 243 million yuan, up 20.68% [3]. Market Position - Steady Medical's total market capitalization is 24.667 billion yuan, ranking 4th in the beauty and personal care industry [3]. - The company has a net asset of 12.276 billion yuan, ranking 1st in the industry, and a net profit of 492 million yuan, ranking 3rd [3]. - The company's price-to-earnings ratio (P/E) is 25.07, which is lower than the industry average of 31.93, ranking 3rd [3]. Fund Flow Analysis - On August 29, 2025, the main funds experienced a net outflow of 47.5893 million yuan, accounting for 6.42% of the total transaction amount [1][2]. - Retail investors showed a net inflow of 48.1353 million yuan, representing 6.49% of the total transaction amount on the same day [1][2]. - Over the past five days, the stock has seen fluctuations in fund flows, with varying levels of net inflows and outflows from main and retail investors [2]. Institutional Ratings - In the last 90 days, 20 institutions have rated the stock, with 17 buy ratings and 3 hold ratings [4]. - The average target price set by institutions over the past 90 days is 55.82 yuan [4].